Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
ZVRA
#2506
Zevra Therapeutics, Inc. Common Stock
8.930
0
+0.68%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+0.68%
Variazione Mensile
0.00%
Variazione di 6 mesi
-16.07%
Variazione Annuale
-16.07%
Chiusura Precedente
8.870
0
Open
8.930
0
Bid
Ask
Low
8.930
0
High
8.930
0
Volume
101
Mercati
Mercato Azionario Statunitense
Salute
ZVRA
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
28.38 M
34.42 M
34.54 M
43.43 M
54.12 M
—
Valuation ratios
Enterprise value
—
—
—
253.55 M
417.54 M
1.72 B
Price to earnings ratio
—
—
—
5.26
3.66
15.31
Price to sales ratio
—
—
—
8.82
16.34
39.01
Price to cash flow ratio
—
—
—
7.22
5.54
40.12
Price to book ratio
—
—
—
3.91
9.72
14.94
Enterprise value to EBITDA ratio
—
—
—
-5.12
-4.81
15.41
Profitability ratios
Return on assets %
1.14
0.06
0.36
0.27
0.59
0.51
Return on equity %
0.19
0.07
0.48
0.74
2.66
1.62
Return on invested capital %
551.89
270.19
707.94
249.94
249.48
426.9
Gross margin %
100
100
96.72
89.28
42.18
308.33
Operating margin %
42.21
26.98
406.44
180.63
368.47
443.72
EBITDA margin %
—
—
-42.2
-180.26
-367.86
131.87
Net margin %
96.03
29.86
397.24
167.69
446.85
600.79
Liquidity ratios
Quick ratio
—
—
—
1.05
2.47
21.45
Current ratio
1.11
27.2
7.93
1.18
2.53
22.02
Inventory turnover
—
—
—
—
2.31
8.41
Asset turnover
1.22
0.4
0.08
0.19
0.13
0.4
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
6.07
0
0.11
0.03
0.33
1.15
Long term debt to total equity ratio
1.02
0
0.15
0.08
1.5
3.94
Per share metrics
Operating cash flow per share
—
0.35
0.54
0.95
1.51
0.48
EBIT per share
—
—
-0.16
-1.42
-2.02
0.85
EBITDA per share
—
—
-0.13
-1.4
-1.88
0.95
Total debt per share
—
—
—
—
—
—
Cash per share
—
3.77
2.4
1.91
1.5
9.82
Net current asset value per share
—
3.87
2.7
2.45
1.86
11.41
Tangible book value per share
—
4.27
2.49
-0.34
-0.74
2.74
Working capital per share
—
3.72
2.36
0.37
1.12
9.2
Book value per share
—
4.27
2.49
1.75
0.86
6.08
Notizie
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates
Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates
Neil F. McFarlane, presidente di Zevra Therapeutics, vende azioni per 125mila dollari
Neil F. McFarlane, Zevra Therapeutics president, sells $125k in shares
Il CMO di Zevra Therapeutics Quartel vende azioni per 40.000 dollari
Joshua Schafer, CCO di Zevra, vende azioni ZVRA per $29.800
Zevra Therapeutics CMO Quartel sells $40k in shares
Schafer Joshua, CCO of Zevra, sells $29,800 in ZVRA stock
Il CEO di Zevra Therapeutics McFarlane vende azioni per 853 mila dollari
Zevra Therapeutics CEO McFarlane sells $853k in shares
Zevra Therapeutics, Inc. (ZVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Zevra Stock: Asymmetric Risk-Reward Setup In Ultra-Rare Disease Market (ZVRA)